Postdoctoral Fellowships on Pain Mechanisms, Neuropharmacology and Opioid Dependence

We discovered new mechanisms by which the body recruits endogenous GPCR signaling in the CNS to prevent the transition from acute injury to chronic pain by (e.g. Corder et al, Science, 2013). We combine in vivo and slice calcium imaging and optogenetics, together with behavioral neuropharmacology, to validate new protein and cellular targets for the treatment of chronic pain and opioid misuse, and to ultimately generate new non-opioid pharmacotherapies and analgesic drugs for neurotrauma, arthritis, diabetes, and multiple sclerosis. For more details on our work and the specifics of each of the three open postdoctoral positions, please see our laboratory web pages  https://www.taylorlab.anes.pitt.edu/

Our group recently moved to the University of Pittsburgh School of Medicine, which currently ranks 5^th among NIH-funded academic medical centers. We are thrilled to launch an Opioid Research Center and to occupy space that is contiguous with 6 of the 7 other core NIH-funded faculty members who make up the Pittsburgh Center for Pain Research http://pcpr.pitt.edu/